About Precision Diagnostics
Precision Diagnostics is a company based in San Diego (United States) founded in 2011 was acquired by BelHealth Investment Partners in May 2014. The company has 358 employees as of December 31, 2021. Precision Diagnostics offers products and services including VerifID, NextGen, UpNEXT, and DDI. Precision Diagnostics operates in a competitive market with competitors including IntegenX, Ameritox, Abreos Biosciences, Psychemedics and American Bio Medica Corporation, among others.
- Headquarter San Diego, United States
- Employees 358 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Precision Diagnostics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$14.5 M (USD), Debt – Venture
Apr 01, 2015
-
Investors
Monroe Capital
& 1 more
-
Employee Count
358
as on Dec 31, 2021
-
Acquired by
BelHealth Investment Partners
(May 01, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precision Diagnostics
Precision Diagnostics offers a comprehensive portfolio of products and services, including VerifID, NextGen, UpNEXT, and DDI.
DNA matching solution for accurate urine specimen identification.
LC-MS/MS technology for reliable drug level detection.
Virtual waiting room for streamlined patient visits.
Platform for identifying drug-to-drug interactions.
People of Precision Diagnostics
Unlock access to complete
Funding Insights of Precision Diagnostics
Investors in Precision Diagnostics
Precision Diagnostics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Monroe Capital and BelHealth Investment Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt financing is offered via specialized funds.
|
Locked | Locked | Locked | |
|
Investment in healthcare businesses, focusing on services, products, and distribution.
|
Locked | Locked | Locked |
Investor details for Precision Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Precision Diagnostics
Investment portfolio details for Precision Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Precision Diagnostics
Detailed financials for Precision Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Precision Diagnostics Comparisons
Peer comparison for Precision Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Precision Diagnostics
Precision Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IntegenX, Ameritox, Abreos Biosciences, Psychemedics and American Bio Medica Corporation, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instruments for rapid human DNA identification are developed.
|
|
| Locked | Locked | Locked |
Pain medication monitoring solutions are provided for US clinicians.
|
|
| Locked | Locked | Locked |
Developing point-of-care tests for personalized dosing and counterfeit detection of biologic drugs
|
|
| Locked | Locked | Locked |
Drug abuse detection services are provided through hair sample testing.
|
|
| Locked | Locked | Locked |
Immunoassay test kits and POC devices are developed and manufactured.
|
Detailed competitors of Precision Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Precision Diagnostics
Complete news archive for Precision Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Precision Diagnostics
Precision Diagnostics was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Precision Diagnostics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
As of Dec 31, 2021, the latest employee count at Precision Diagnostics is 358.
Precision Diagnostics, formerly known as Precision Toxicology, provides quantitative confirmation urine drug testing services that allow physicians to monitor patients on chronic opioid therapy. Its test panel technology tests for various prescription medications, as well as illicit drugs. Services include NextGen Precision Testing platform; Precision TBM, a Toxicology Benefit Management program to better manage the clinical drug testing benefit; SOF-Adhere , to detect the amount of the sofosbuvir metabolite in a patients urine sample and Oral fluid testing. It is a BelHealth portfolio company since April 2014.
Precision Diagnostics's top competitors include IntegenX, Psychemedics and Ameritox.
Precision Diagnostics offers VerifID, NextGen, UpNEXT, and DDI.
Precision Diagnostics has 2 investors. Key investors include Monroe Capital, and BelHealth Investment Partners.